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G protein-coupled receptors (GPCRs) mediate the biological effects of many 19 
hormones and neurotransmitters and are major pharmacological targets1. They 20 
transmit their signals to the cell interior via interaction with G proteins. However, 21 
how receptors and G proteins meet, interact and couple is still ill understood. 22 
Here, we analyse the concerted motion of GPCRs and G proteins on the plasma 23 
membrane and provide a quantitative model that reveals the key factors at the 24 
basis of the high spatiotemporal complexity of their interactions. Using two-25 
colour, single-molecule imaging we visualize interactions between individual 26 
receptors and G proteins at the surface of living cells. Under basal conditions, 27 
receptors and G proteins form activity-dependent complexes that last for ~1 28 
second. Different agonists specifically regulate the kinetics of receptor-G protein 29 
interactions, mostly increasing their association rate. We find hot spots on the 30 
plasma membrane, at least partially defined by the cytoskeleton and clathrin-31 
coated pits, where receptors and G proteins are confined and preferentially 32 
couple. Imaging with the nanobody Nb37 suggests that signalling preferentially 33 
occurs at these hot spots. These findings shed new light on the dynamic 34 
interactions governing GPCR signalling.  35 
Different scenarios have been developed to explain how receptors and G proteins interact2,3. 36 
However, key questions concerning the stability of these interactions and the occurrence of 37 
GPCR signalling subdomains at the plasma membrane are still open (see also Supplementary 38 
Discussion). To address these questions, we visualized individual receptors and G proteins at 39 
the surface of living cells with high spatial (≈20 nm) and temporal (≈30 ms) resolution4. As a 40 
model, we chose the α2A-adrenergic receptor (α2A-AR), a prototypical family-A GPCR with 41 
strong Gi coupling2. The α2A-AR and a pertussis toxin (PTX)-insensitive Gαi1 construct were 42 
specifically labelled with two different organic fluorophores via a SNAP5 or CLIP6 tag, 43 
respectively (Fig. 1a); both constructs were fully functional (Extended Data Fig. 1a, b). These 44 
constructs were transiently expressed at low physiological densities (0.55±0.10 and 0.51±0.09 45 
molecule μm-2, respectively) in CHO cells − cultured with PTX to inactivate endogenous Gi/o 46 
proteins − and simultaneously imaged by fast two-colour single-molecule microscopy combined 47 
with single-particle tracking4 (Fig. 1b and Supplementary Videos 1 and 2). Labelling efficiencies 48 
were ~90% (extracellular) and ~80% (intracellular); non-specific labelling was <1% (Extended 49 
Data Fig. 1c-e). 50 
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Individual α2A-AR trajectories were evaluated by mean square displacement (MSD) analysis 51 
(corrected for localization error, see Supplementary Methods), which revealed a high 52 
heterogeneity and features of anomalous diffusion7. Under basal conditions, 11% of the 53 
receptors were virtually immobile, while 38% had sub-, 45% normal and 6% super-diffusion (i.e. 54 
directional motion) (Extended Data Fig. 2). Gαi had a significantly different diffusion pattern, with 55 
a larger immobile fraction (37%) (Extended Data Fig. 2c, d). Stimulation with the full agonist 56 
norepinephrine (NE) or brimonidine (UK-14,304) caused a small, significant change in the 57 
overall diffusion pattern of Gαi but not of α2A-AR (Extended Data Fig. 2d). Similar results were 58 
obtained for a second receptor/G protein pair, i.e. β2-adrenergic receptor (β2-AR) and Gαs, but 59 
no significant differences were observed upon stimulation with the full agonist isoproterenol (Iso; 60 
Extended Data Fig. 2d). 61 
We then analysed the trajectories with an algorithm based on hidden Markov models (HMMs)8, 62 
which assumes that particles switch among discrete diffusive states following a stochastic 63 
process. We found that both receptors and G proteins frequently switched among at least four 64 
distinguishable states (S1 to S4), characterized by distinct diffusion coefficients (D) and ranging 65 
from a virtually immobile (S1) to a fast diffusive (S4) state (Fig. 1c-f and Extended Data Fig. 3). 66 
The results were overall consistent with those of the MSD analysis. We hypothesized that the 67 
two slowest states (S1 and S2) were due to trapping in small membrane compartments and, 68 
based on the corresponding D and average dwell times, we estimated compartment radiuses of 69 
<50 nm and ~270 nm, respectively (see Supplementary Methods). Although with some 70 
differences, a similar picture was observed for the integral membrane protein CD86 – used as 71 
control4 (Fig. 1f, Extended Data Figs. 2d and 3), indicating that such diffusion behaviour is not 72 
unique to GPCRs/G proteins. 73 
Density maps of single-molecule localizations revealed areas that were either preferentially 74 
explored or avoided by α2A-ARs and Gαi subunits (Extended Data Fig. 4a and Supplementary 75 
Video 3). To better characterize these areas, we generate dynamic maps from the trajectories, 76 
reporting local D and potential energy (V) values9. This analysis revealed a complex dynamic 77 
landscape at the plasma membrane, with high-potential areas, which were rapidly left by α2A-78 
ARs/Gαi subunits, and low-potential areas, where they tended to be trapped (Extended Data 79 
Fig. 4b, dark areas; see Extended Data Fig. 1f for control). There was a partial but consistent 80 
overlap between the potential energy maps of α2A-ARs and Gαi subunits (Extended Data Fig. 81 
4c). To quantify this, we measured the relative potential energy values (VL,rel) of Gαi at the sites 82 
of α2A-AR localization and vice versa, which were both significantly lower than for random 83 
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localizations or compared to CD86 (Fig. 2a). Importantly, receptor:G protein interactions 84 
preferentially occurred at the shared low potential energy areas (“hot spots”), as indicated by 85 
negative VL,rel values (Fig. 2b). Similar results were obtained for β2-AR and Gαs (Extended Data 86 
Fig. 5a, b).  87 
To investigate possible factors responsible for this complex diffusion dynamics, we imaged both 88 
the cytoskeleton and clathrin-coated pits (CCPs) underneath the plasma membrane. α2A-ARs 89 
trajectories tended to avoid microtubules and actin fibres, as suggested by negative 90 
colocalization index values (Fig 2c, d, Supplementary Videos 4 and 5), in agreement with the 91 
fence-and-picket model10. Moreover, the majority of trajectories tended to avoid CCPs (Fig. 2e, 92 
Supplementary Video 6). This coexisted with a minor fraction of α2A-ARs that either transiently 93 
stopped at CCPs (Fig. 2f, arrowheads) − consistent with receptor recruitment to pre-existing 94 
CCPs11 − or were immobile and localized at CCPs. The fraction of CCPs occupied by α2A-ARs 95 
increased upon agonist stimulation (Fig. 2f, right), Overlays of single particle trajectories with 96 
superresolved actin images, obtained by photoactivated localization microscopy (PALM)12, 97 
suggested that the actin mesh underneath the plasma membrane created sub-micrometre 98 
compartments in which α2A-ARs were apparently loosely trapped (Fig. 2g and Supplementary 99 
Video 7; radius ~100-300 nm, in agreement with estimation based on HMM analysis). 100 
Consistently, superimposition of PALM images with potential energy maps showed that the low 101 
potential areas were often at least partially delimited by actin fibres (Fig. 2h and Extended Data 102 
Fig. 4d). Similar results were obtained for β2-AR (Extended Data Fig. 5c-f) and Gαi (Extended 103 
Data Fig. 6 and Supplementary Video 8). 104 
Next, we developed a mathematical analysis to estimate the duration of receptor:G protein 105 
interactions based on their trajectories. We reasoned that, on average, for two particles 106 
undergoing a true interaction, their observed colocalization time (Δtobs) should correspond to the 107 
average duration of true interactions (Δttrue) plus the average duration of random colocalizations 108 
(Δtrandom) (Fig. 3a and Extended Data Fig. 7). Thus, we deconvolved the observed colocalization 109 
times with those of random colocalizations (obtained with CD86 and Gαi) to estimate the 110 
distribution of the underlying true receptor:G protein interactions (Fig. 3b and Supplementary 111 
Methods). The results were subsequently expressed as normalized relaxation curves, showing 112 
the fraction of the interactions that are still ongoing at time t from the beginning of each 113 
interaction (Fig. 3c). The very fast component in Fig. 3b, seen also with the control CD86, 114 
corresponds to non-productive interactions plus random colocalizations, the rate of which (knp+rc) 115 
did not differ among the conditions tested (Fig. 3d, left), while we considered the remainder to 116 
5 
 
be productive interactions, i.e. interactions that result in the formation of a “true” complex (see 117 
Supplementary Discussion). α2A-ARs and Gαi underwent some productive interactions already 118 
under basal conditions (Fig. 3b, c). A major fraction of these interactions terminated following an 119 
exponential decay, while a very small fraction (approximately 3·10-4) was stable over the 120 
observation time (Fig. 3c). From a fitting of the major component in Fig. 3c and the particle 121 
densities we estimated an association rate constant (kon) of ~0.015 μm2 molecule-1 s-1 and a 122 
dissociation rate constant (koff) of ~0.8 s-1 for the productive interactions under basal conditions 123 
(Fig. 3d, middle/right). Treatment with an inverse agonist (yohimbine) or Gαi inactivation (using 124 
a PTX-sensitive construct) suppressed the major fraction of transient productive interactions, 125 
suggesting that they resulted from constitutive α2A-AR activity and required a functional Gαi 126 
subunit; in contrast, the small fraction of stable productive interactions was not affected (Fig. 127 
3e). Stimulation with norepinephrine caused a concentration-dependent increase of kon up to 128 
~0.2 μm2 molecule-1 s-1, while koff was only marginally affected (Fig. 3b-d). This translates into 2-129 
dimensional equilibrium dissociation constants (Kd) of ~50 and 6 molecule μm-2 for basal and 130 
stimulated conditions, respectively. Based on these results, we estimated that, at the tested 131 
densities, ~0.5% (basal) or 5% (stimulated) of all α2A-ARs were in complex with Gαi at any given 132 
time. Similar results were obtained for β2-AR:Gαs interactions, although with 10-fold lower kon 133 
values and no long-lived interactions (Fig. 3f, g). A panel of α2A-AR agonists with varying 134 
efficacy and affinity revealed statistically significant differences in the estimated kon and, to a 135 
lesser extent, koff values (Fig. 3d). Overall, there was a positive correlation between kon and 136 
efficacy (Fig. 3h). However, there was also a trend towards smaller kon values for higher affinity 137 
agonists, both considering full (UK-14,304 vs. norepinephrine) or partial (clonidine vs. 138 
oxymetazoline) agonists with comparable efficacies and dissimilar affinities (Fig. 3d, h). 139 
By visually inspecting the trajectories, we observed that several α2A-ARs and Gαi subunits 140 
slowed down or stopped during apparent interactions to then either remain confined or resume 141 
their motion (Fig. 3i, Fig 3j, left and Supplementary Video 9), while the remainder retained their 142 
mobility (Fig. 3j, right). A quantitative analysis of the HMM states of α2A-AR and Gαi trajectories 143 
showed that, during the time of interaction, higher fractions of receptors/G proteins were in 144 
states S1 (virtually immobile) and S2 (slowly diffusing) (Fig. 3k). These mobility changes 145 
occurring during the short interaction times and the global changes in Gαi diffusion described in 146 
Extended Data Fig. 2d and 3 likely represent distinct phenomena. 147 
To further validate our results, we performed deterministic simulations of GPCR signalling using 148 
the estimated microscopic kon and koff values for receptor:G protein interactions. The results 149 
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were in very good agreement with ensemble (FRET) measurements of α2A-AR/Gi 150 
association/dissociation (Extended Data Fig. 8). These simulations also suggested that G 151 
protein signalling can be fast only if it occurs while the G protein is still bound to the receptor 152 
(Supplementary Data). Moreover, we performed particle-based stochastic simulations of 153 
receptors and G proteins diffusing and interacting on a 2D surface (Fig 4a). Introducing the 154 
experimentally measured potential energy (V) landscapes (as in Fig. 2b) in these simulations 155 
doubled the probability of receptor:G protein interactions compared to conditions of simple 156 
Brownian motion (Fig. 4a). 157 
To investigate whether hot spots for receptor:G protein interactions also occur in a more 158 
physiological context, we studied primary human endothelial cells (HUVEC), where both α2A- 159 
and β2-ARs are endogenously expressed and regulate vascular tone13. We found that in these 160 
cells both α2A-AR:Gαi and β2-AR:Gαs interactions were preferentially occurring at low potential 161 
energy areas (Extended Data Fig. 9a, b). We also found that receptors and G proteins slowed 162 
down or stopped moving during their interactions (Extended Data Fig. 9c), further strengthening 163 
our observations in CHO cells. 164 
Finally, we assessed Gs activation using the conformation-sensitive nanobody Nb3714,15, which 165 
recognizes the active (nucleotide-free) state of Gαs. In HUVEC transfected with Nb37 fused to a 166 
fluorescent protein (EYFP), Nb37 preferentially localized at the sites where β2-ARs were 167 
concentrated (Fig. 4b). 168 
The main findings of our study are summarized in Extended Data Figure 10. First, our results 169 
reveal a complex picture, whereby barriers, at least partially constituted by actin fibres, 170 
microtubules and CCPs, contribute to the formation of hot spots where receptors and G proteins 171 
are both concentrated, and where G protein coupling as well as signalling preferentially occur. 172 
This provides a direct visualization of previously postulated GPCR signalling nanodomains16,17. 173 
Based on our results and simulations, we hypothesize that this complex organization increases 174 
both the speed and efficiency of receptor:G protein coupling, while allowing G protein signalling 175 
to occur locally. 176 
Second, our data provide direct estimates of the frequency and duration of receptor:G protein 177 
interactions in living cells. We find that most receptor:G protein interactions are short-lived 178 
(lifetime ~1-2 s). The dependency of these complexes on receptor activation suggests that they 179 
are linked to signalling, which is further supported by the observation that G protein activation 180 
occurs preferentially at the sites of interaction. In addition, we observe a very small fraction of 181 
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long-lived complexes (lifetime >> 4s), possibly corresponding to those reported in previous 182 
studies3,18. The coexistence of short- and long-lived complexes might reconcile earlier 183 
contrasting data. Intriguingly, the estimated duration of the short-lived interactions is much 184 
longer than the time required for effector activation, which can happen in ~40 ms2. Thus, as 185 
suggested by our deterministic simulations, it is conceivable that fast effector activation might 186 
occur while the G protein is still bound to the receptor19. 187 
Third, our results reveal that receptor:G protein interactions are regulated by agonists largely at 188 
the level of kon. The low kon values measured here also indicate that random collisions only 189 
seldom lead to the formation of productive receptor:G protein complexes. The fact that kon is 190 
regulated by agonists and the low kon values suggest that receptor:G protein interactions are not 191 
limited by diffusion, but rather by the major conformational changes occurring during the 192 
formation of receptor:G protein complexes14,20-22 (see also Supplementary Discussion). 193 
Interestingly, different agonists induce substantially different kon values, which correlate at least 194 
partially with their efficacies. Together with small differences in the koff values, these findings 195 
suggest the possibility of fine-tuning receptor signalling using drugs with tailored effects on the 196 
kinetics of receptor:G protein interactions. Finally, our finding of lower kon values for β2-AR:Gαs 197 
than for α2A-AR:Gαi interactions is consistent with the view that coupling to Gs might require a 198 
larger conformational change than coupling to Gi23. 199 
In summary, our single-molecule results reveal new key factors involved in the regulation of 200 
receptor:G protein interactions, which may allow modifying receptor signalling in ways that far 201 
exceed simple receptor blockade or activation achieved with currently available drugs, for 202 
example by modulating the on/off rates of receptor:G protein interactions or manipulating 203 
receptor/G protein mobility and coupling at the hot spots. They further illustrate how GPCR 204 
signalling results from dynamic interactions among receptors, G proteins and the complex 205 
surrounding membrane environment, which confers flexibility and versatility to this fundamental 206 
biological process. 207 
 208 
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Figure Legends 286 
Figure 1 | Single-molecule imaging of receptors/G proteins. a, Overall strategy. The α2A-AR 287 
was labelled with S549-BG via a SNAP tag fused to its N-terminus. The Gi protein was labelled 288 
with SiR-BC via a CLIP tag inserted in an internal loop of the Gαi subunit. b, Selected frame 289 
from a fast single-molecule image sequence (left) and corresponding trajectories (right). c-e, 290 
HMM analysis of diffusive states. Shown is a representative α2A-AR trajectory (c), with its 291 
displacement (r) over time (d) and the result of the global HMM analysis (e) revealing 4 states 292 
(S1-S4, labelled with different colours). f, Model and diffusion coefficients (D; μm2 s-1) derived 293 
from the HMM analysis. Each state is represented by a solid circle; circle area and arrow 294 
thickness proportional to occupancy and transition probability, respectively. Differences were 295 
statistically significant by two-way ANOVA. *, P<0.05, **, P<0.01, ***, P<0.001, ****, P<0.0001 296 
vs. corresponding state of α2A-AR by Tukey's multiple comparison test. Data are mean±s.d. 297 
n=22 (85,475), 13 (47,062) and 28 (110,907) cells (trajectories) for α2A-AR, Gαi and CD86, 298 
respectively. Images (b, c) represent 5 independent experiments. 299 
 300 
Figure 2 | Complex diffusion dynamics generates hot spots for receptor:G protein 301 
interactions. a, α2A-AR localizations over Gαi potential energy map (left) and quantifications of 302 
relative potential energy at the localizations (VL,rel; right). b, α2A-AR:Gαi interactions over merged 303 
α2A-AR and Gαi potential energy (V) maps (left) and corresponding quantifications (right). 304 
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Arrowheads, localizations concentrated at hot spots. c-e, α2A-AR trajectories over images of 305 
tubulin (c), actin (d) or CCPs (e) (left) and corresponding colocalization analyses (right). f, 306 
Trajectories of α2A-ARs (colour-coded according to HMM states) stopping at CCPs (arrowheads; 307 
left) and corresponding quantitative analysis (right). g, α2A-AR trajectories over actin PALM 308 
image (left) and corresponding colocalization analysis (right). Arrowheads, α2A-ARs crossing 309 
over actin fibres. h, α2A-AR potential energy map over actin PALM image (left) and zoom-in view 310 
showing hot spot surrounded by actin fibres (right). α2A-ARs in g and h were labelled with S647-311 
BG. Results (a-e, g) were compared to random localizations. See Supplementary Methods for 312 
details. Data are mean±s.d. n, number of cells. #, P<0.05, ##, P<0.01, ###, P<0.001, ####, 313 
P<0.0001 vs. random localizations by two-sided paired t-test. *, P<0.05, ****, P<0.0001 vs. α2A-314 
AR (basal) by two-sided unpaired t-test. Images (h) represent 2 independent experiments. 315 
 316 
Figure 3 | Analysis of receptor:G protein interactions. a, Schematic comparison between 317 
random colocalizations and true interactions. On average, the observed duration of true 318 
interactions (Δtobs) corresponds to their true duration (Δttrue) plus that of random colocalizations 319 
(Δtrandom). The distribution of true durations can then be estimated via deconvolution. b, 320 
Distributions of the estimated durations of α2A-AR:Gαi interactions under basal and stimulated 321 
(NE, 100 μM) conditions, based on deconvolution. CD86 was used as non-interacting control. c, 322 
Relaxation curves calculated from the data in b, showing the dissociation kinetics of α2A-AR:Gαi 323 
complexes (left, linear; right, semilogarithmic plot). d, Estimated rate constants of non-324 
productive interactions plus random colocalizations (knp+rc; left), α2A-AR:Gαi association (kon; 325 
middle) and dissociation (koff; mean, 95%CI; right) for the indicated ligands. Differences in kon 326 
values are statistically significant by one-way ANOVA. ****, P<0.0001 vs. NE 100 μM by Tukey's 327 
multiple comparison test. Differences in koff values vs. NE 100 μM were assessed by two-sided 328 
unpaired t-test with Bonferroni correction (****, P<0.0001). e, Relaxation curves of α2A-AR:Gαi 329 
interactions obtained with an inverse agonist (yohimbine) or using a PTX-sensitive Gαi 330 
construct. f, Relaxation curves of β2-AR:Gαs interactions. g, Estimated kon and koff (mean, 331 
95%CI) for β2-AR:Gαs interactions. ****, P<0.0001 vs. Iso by two-sided unpaired t-test. h, 332 
Relationship between measured kon and efficacy on α2A-AR activation (mean±s.e.m.). Brackets, 333 
affinity values (pKi). Efficacy and affinity values are from ref. 24. i, Apparent interaction between 334 
α2A-AR and Gαi lasting for 1.2 s. After the interaction, the receptor resumes moving, whereas 335 
the G protein remains immobile. j, α2A-AR and Gαi trajectories stopping (left) or continuing 336 
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moving (right) during apparent interactions. k, Distribution of diffusive states (based on HMM 337 
analysis) of α2A-AR and Gαi (NE, 100 μM) during apparent interactions (colocalization duration ≥ 338 
1.1 s) compared to time outside interactions. Differences are statistically significant by chi-339 
square test (****, P<0.0001; n=1,265,634 and 527,058 data points for α2A-AR and Gαi, 340 
respectively). All ligands were used at saturating concentrations, unless otherwise indicated. 341 
See Supplementary Methods for details. Data are mean±s.d., unless otherwise indicated. n, 342 
number of cells (d, g). Images (i, j) represent 5 independent experiments. N.D., not 343 
determinable. 344 
 345 
Figure 4 | Hot spots for receptor-G protein signalling. a, Stochastic simulations of 346 
receptor:G protein interactions. Left, simulated trajectories. Right, fraction of interacting 347 
molecules over time. Compared are results with experimentally measured potential energy (V) 348 
landscapes vs. simple Brownian motion. b, Visualization of local Gs protein activation at the 349 
plasma membrane of primary human endothelial cells. Cells were transfected with a fluorescent 350 
sensor (Nb37-EYFP) recognizing active, nucleotide-free Gαs. Left, β2-AR localizations over the 351 
obtained spatial map of Gs protein activity. Right, quantification. Data are mean±s.d. n, number 352 
of cells. ####, P<0.0001 vs. random localizations by two-sided paired t-test. 353 
 354 
Methods 355 
Materials 356 
Cell culture reagents, Lipofectamine 2000, Lipofectamine 3000, TetraSpeck fluorescent beads, 357 
fluorescein arsenical hairpin binder (FlAsH) and CellMask Green Plasma Membrane Stain were 358 
from Thermo Fisher Scientific. The Effectene transfection reagent was from Qiagen. UK-14,304 359 
and clonidine were from Tocris Bioscience. All other GPCR ligands, pertussis toxin (PTX), 1,2-360 
ethanedithiol (EDT) and guanosine 5′-triphosphate (GTP) were from Sigma-Aldrich. [35S]GTPγS 361 
was from PerkinElmer. The fluorescent benzyl guanine derivatives SNAP-Surface 549 (S549-362 
BG) and SNAP-Surface Alexa Fluor 647 (S647-BG) were from New England Biolabs. Live-cell 363 
fluorogenic probes for actin (SiR-Actin) and tubulin (SiR-Tubulin)25 were from Spirochrome. The 364 
silicon-rhodamine benzyl cytosine derivative (SiR-BC)26 was kindly provided by Kai Johnsson 365 
(Max Planck Institute for Medical Research, Heidelberg, Germany). Ultraclean glass coverslips 366 
were obtained as previously described4. 367 
 368 
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Molecular biology 369 
A plasmid coding for the N-terminally SNAP-tagged α2A-adrenergic receptor (SNAP-α2A-AR) 370 
was generated by inserting the SNAP tag5 before the coding sequence of the murine α2A-371 
adrenergic receptor. The generation and functional characterization of the N-terminally SNAP-372 
tagged β2-adrenergic receptor construct (SNAP-β2-AR) have been described in a previous 373 
study4. A plasmid (Gαi-CLIP) coding for the rat Gαi1 subunit with the CLIP tag6 inserted in the 374 
αA-αB loop within the α-helical domain (between positions 91 and 92) was generated by 375 
replacing YFP with the CLIP tag in a previously described YFP-tagged Gαi1 construct27. The 376 
construct additionally harboured the C351I mutation to render it PTX-insensitive28. A plasmid 377 
coding for the rat Gαs subunit with the CLIP tag inserted between positions 72 and 85 (Gαs-378 
CLIP) was generated by replacing YFP with the CLIP tag in a previously described YFP-tagged 379 
Gαs construct29. All tagged receptor and Gα subunit constructs behaved like the corresponding 380 
wild type in functional assays (Extended Data Fig. 1a, b). A construct coding for His-tagged 381 
Nb3714 was kindly provided by Jan Steyaert (VIB, Brussels, Belgium). A plasmid coding for the 382 
C-terminally EYFP-tagged Nb37 (Nb37-EYFP) was generated by fusing EYFP to the C-terminus 383 
of Nb37. Plasmids coding for CD86 with either one or two SNAP tags fused to its N-terminus 384 
have been previously described4. Plasmids coding for CD86 with either one or two CLIP tags 385 
fused to its C-terminus were generated by inserting either one or two copies of the CLIP tag 386 
before the stop codon of CD86. 387 
 388 
Cell culture and transfection 389 
Chinese hamster ovary K1 (CHO-K1) cells (ATCC) were cultured in phenol red-free Dulbecco's 390 
modified Eagle's medium (DMEM)/F-12 supplemented with 5% FCS, 100 U/ml penicillin and 0.1 391 
mg/ml streptomycin at 37 °C, 5% CO2. For single-molecule experiments, CHO-K1 cells were 392 
seeded on ultraclean 24-mm glass coverslips in 6-well culture plates at a density of 3·105 393 
cells/well. Cells were treated with 50 ng/ml pertussis toxin (PTX) to inactivate endogenous Gαi/o 394 
proteins. Transfection was performed 24 h after seeding using Lipofectamine 2000. For each 395 
well, 0.8 μg SNAP-α2A-AR or SNAP-β2-AR, 0.6 μg Gαi-CLIP or Gαs-CLIP, 0.4 μg Gβ1, 0.2 μg 396 
Gγ2, and 6 μL Lipofectamine 2000 were used. Cells were labelled and imaged by single-397 
molecule microscopy 4-6 h after transfection to obtain low physiological expression levels4. To 398 
label CCPs, cells were transfected 24 h prior to the experiment with GFP-tagged adaptor protein 399 
2 (AP2-GFP), kindly provided by Tom Kirchhausen (Harvard Medical School, USA). Human 400 
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embryonic kidney 293 (HEK293) cells (ATCC) were cultured in DMEM supplemented with 5% 401 
FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin at 37 °C, 5% CO2. HEK293 cells were 402 
transfected with Effectene, following the manufacturer’s instructions. Cell lines have not been 403 
authenticated. Cells were routinely tested for mycoplasma contamination by PCR using specific 404 
primers. 405 
For the [35S]GTPγS binding experiments, HEK293 cells were plated in 10-cm culture dishes and 406 
transfected with 3.3 μg α2A-AR, 3.3 μg wild-type or CLIP tagged Gαi, 2.0 μg Gβ1 and 1.5 μg Gγ2 407 
plasmids.  408 
For FRET experiments, HEK293 cells were seeded on poly-L-lysine−coated 24-mm coverslips 409 
and transfected with the indicated constructs. The α2A-AR-Flash/CFP sensor was used to 410 
monitor receptor activation30. Co-transfection of α2A-AR-YFP, Gαi-CFP, Gβ1 and Gγ2 was used to 411 
monitor G protein recruitment to the receptor2. The Gβ1-2A-cpV-Gγ2-IRES-Gαi2-mTq2 sensor31 412 
was used to monitor Gi protein activation. 413 
Human umbilical vein endothelial cells (HUVEC) were purchased from Lonza and cultured in 414 
complete EGM-2 BulletKit medium (Lonza). HUVEC were plated on ultraclean 24-mm glass 415 
coverslips at a density of 3.5·105 cells/well and transfected with Lipofectamine 3000 using the 416 
same DNA amounts indicated for CHO cells. HUVEC were cultured for a maximum of 10 417 
passages. To visualize local Gs protein activation at the plasma membrane, HUVEC were 418 
transfected 24 h prior to the experiment with the Nb37-EYFP construct. 419 
 420 
[35S]GTPγS binding assay 421 
Membrane preparation and [35S]GTPγS binding assay were performed following a previously 422 
described protocol32. Cells were homogenized in lysis buffer (5 mM Tris, 2 mM EDTA, pH 7.4) 423 
and then centrifuged at 1,000xg for 10 min. The supernatant was collected and centrifuged at 424 
50,000xg for 30 min. The remaining pellet was resuspended in binding buffer (100 mM NaCl, 10 425 
mM MgCl2, 20 mM HEPES, pH 7.4). All procedures were performed at 4 °C. Protein 426 
concentrations were determined using the Bradford assay. 10 μg membrane proteins were then 427 
incubated with the indicated agonist concentrations and 100 pM [35S]GTPγS for 15-300 s. Non-428 
specific binding was evaluated by adding 10 μM GTP. The samples were then passed through 429 
glass fibre filters and radioactivity was determined using a liquid scintillation counter (Beckman 430 
LS-1801). 431 
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 432 
Live-cell protein labelling 433 
Cells were labelled with a combination of a cell-impermeable SNAP substrate (S549-BG), to 434 
label cell-surface receptors, and a highly cell-permeable CLIP substrate (SiR-BC)26, to label 435 
intracellular G proteins. Cells were incubated with 4 μM S549-BG and 8 μM SiR-BC in complete 436 
culture medium for 20 min at 37 °C. Cells were then washed three times using complete culture 437 
medium, with 5 min incubation after each wash. This protocol gives labelling efficacy of ~90% 438 
and ~80% for extracellular SNAP and intracellular CLIP labelling, respectively (Extended Data 439 
Fig. 1c, d). 440 
Actin and tubulin labelling were performed using SiR-actin and SiR-tubulin, respectively, 441 
following the manufacturer’s protocol. Briefly, cells were labelled with 3 μM SiR-actin or SiR-442 
tubulin in the presence of 10 μM verapamil for 20 min at 37 °C, followed by three washes with 443 
complete culture medium. 444 
FlAsH labelling was performed as previously described30. Briefly, cells were incubated with 1 μM 445 
FlAsH and 12.5 μM EDT in Hank's balanced salt solution (HBSS) for 1 h. The cells were then 446 
washed twice with HBSS and incubated with 250 μM EDT in HBSS for 10 min. The cells were 447 
washed a third time with HBSS immediately before the FRET measurement. 448 
 449 
FRET measurements 450 
Fluorescence resonance energy transfer (FRET) experiments to examine the ensemble kinetics 451 
of receptor/G protein signalling in intact cells were done as previously described2,33,34. 452 
Measurements were performed on an Axiovert 200 inverted microscope (Zeiss) equipped with 453 
an oil immersion 100X objective (Plan-Neofluar 100x, N.A. 1.30), a beamsplitter (DCLP505) and 454 
a Polychrome IV monochromator and dual-emission photometric system (Till Photonics). 455 
Transfected HEK293 cells were placed in a microscopy chamber filled with imaging buffer (137 456 
mM NaCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH 7.3). Agonist stimulation 457 
was applied using a pressurized rapid superfusion system (ALA-VM8, ALA Scientific 458 
Instruments). FRET was monitored as the ratio between YFP (535±15 nm) and CFP (480±20) 459 
emission upon CFP excitation at 436±10 nm. The YFP signal was corrected for direct excitation 460 
and bleed-through of CFP emission into the YFP channel as previously described2. 461 
 462 
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Single-molecule microscopy and PALM 463 
Single-molecule microscopy experiments were performed using total internal reflection 464 
fluorescence (TIRF) illumination on a custom Nikon Eclipse Ti TIRF microscope equipped with 465 
405 nm, 488 nm, 561 nm and 640 nm diode lasers (Coherent), a quadruple band excitation 466 
filter, a 100x oil-immersion objective (CFI Apo TIRF 100x, N.A. 1.49), two beam splitters, four 467 
separate EMCCD cameras (iXon DU897, Andor), hardware focus stabilization and a 468 
temperature control system. Coverslips were mounted in a microscopy chamber filled with 469 
imaging buffer. The objective and the sample were maintained at 20 °C by means of a water-470 
cooled inset and objective ring connected to a thermostated water bath. Images in the four 471 
channels were acquired simultaneously on the four separate EMCCD cameras. Image 472 
sequences (400 frames) were taken in crop and frame-transfer mode, resulting in an acquisition 473 
speed of 35 frames/s (i.e. one image every 28 ms). 474 
PALM imaging was performed by TIRF microscopy immediately after the acquisition for single-475 
particle tracking. In this case, cells were additionally transfected 24 h before the experiment with 476 
the photoconvertible probe mEOS-LifeAct (a kind gift of Markus Sauer, University of Würzburg, 477 
Germany). mEOS was excited at 561 nm, while applying low-intensity 405 nm laser light to 478 
induce photoconversion. 10,000 frames were acquired at a speed of 35 frames/s. 479 
Superresolved images were then obtained using the rapidSTORM software35. 480 
Images from different channels were registered against each other using a linear piecewise 481 
transformation in Matlab based on reference points obtained with multicolour fluorescent beads 482 
(TetraSpeck; 100 nm size). 483 
 484 
Single particle tracking and subsequent analyses 485 
Single particle detection and tracking were performed using the u-track software36 in Matlab 486 
environment as previously described4. The interchannel localization precision after coordinate 487 
registration by linear piecewise transformation was ~20 nm. For the analysis of receptor:G 488 
protein interactions, a non-related membrane receptor (CD86) with diffusion characteristics 489 
comparable to those of the α2A-AR was used as negative control and as reference for random 490 
colocalizations4. A method based on deconvolution of the observed interaction times with the 491 
Lucy-Richardson algorithm37,38 was then applied to estimate the underlying duration of 492 
receptor:G protein interactions (see Supplementary Methods and Extended Data Fig. 7). 493 
To investigate the motion of receptors and G proteins during or immediately before/after an 494 
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interaction (Fig. 3i-k and Extended Data Fig. 9c), we considered only apparent interactions with 495 
duration ≥ 1.1 s, so that random colocalization represented only a small fraction (approximately 496 
15%), based on a comparison between α2A-AR (NE 100 μM) and CD86 (used as negative 497 
control). 498 
Detailed information about the computational analyses can be found in Supplementary 499 
Methods. 500 
 501 
Hidden Markov model (HMM) analysis 502 
A software based on a variational Bayesian treatment of HMMs (vbSPT)8 was used to identify 503 
discrete diffusive states in the single molecule trajectories and analyse their characteristics. The 504 
number of iterations and bootstrapping were set to 25 and 100, respectively. Diffusion 505 
coefficients and dwell times derived from the analysis were used to estimate the size of the 506 
corresponding nanocompartments on the plasma membrane (see Supplementary Methods). 507 
 508 
Spatial mapping of receptor/G protein dynamics 509 
Spatial maps of diffusivity (D) and potential energy (V) were obtained using the InferenceMAP 510 
software9, based on Bayesian inference, considering a physical model of diffusion in a potential 511 
field. Only well-adhering cells with a flat plasma membrane were chosen to avoid artefacts due 512 
to uneven distance from the coverslip. The flatness of the plasma membrane was verified by 513 
staining with a fluorescent phospholipid (CellMask Green). The analysed areas were partitioned 514 
in small regions of variable size by Voronoi tessellation9. The number of regions was optimized 515 
to avoid areas with low number of localizations. The obtained potential energy maps were 516 
subsequently used to perform particle-based stochastic simulations of receptor:G protein 517 
interactions (see Supplementary Methods). 518 
 519 
Statistics and reproducibility 520 
Statistical analyses were performed using the Prism 6 software (GraphPad Software). 521 
Differences between two groups were assessed by two-sided Student´s t-test. Differences 522 
among three or more groups were assessed by one-way or two-way analysis of variance 523 
(ANOVA), as appropriate, followed by Tukey's multiple comparison test (with the exception of 524 
the data in Figure 3d, right, which were compared by two-sided unpaired t-test with Bonferroni 525 
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correction). Differences in categorical variables were assessed by chi-square test. Differences 526 
were considered significant for P values < 0.05. 527 
 528 
Data availability 529 
The data that support the findings of this study are available from the corresponding author 530 
upon reasonable request. 531 
 532 
Code availability 533 
Matlab scripts are available from the corresponding author upon reasonable request. 534 
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 567 
Extended Data Figure legends 568 
Extended Data Figure 1 | Control experiments. a-c, Functional characterization of the 569 
SNAP/CLIP tagged receptor/G protein constructs. a, FRET measurements of Gi protein 570 
activation to test the SNAP-tagged α2A-AR construct. HEK-293 cells were co-transfected with a 571 
FRET sensor for Gi protein activation (Gβ1-2A-cpV-Gγ2-IRES-Gαi2-mTq2) and either wild-type or 572 
SNAP-tagged α2A-AR (n=9, 11 cells). Concentration response relationships were obtained from 573 
FRET measurements in which the cells were stimulated with increasing concentrations of NE. 574 
The SNAP-tagged β2-AR construct was tested in a previous study4. b, GTPγS binding assay to 575 
test the CLIP-tagged Gαi and Gαs constructs. The corresponding wild-type constructs were 576 
used as control. Shown are time courses of GTPγS binding in the presence or absence of 577 
agonist (left, clonidine, 10 μM; right, isoproterenol, 10 μM) (n=3 biological replicates per 578 
condition). c, Efficiency of extracellular labelling with the cell impermeable SNAP substrate 579 
S549-BG in cells transfected with CD86 carrying two SNAP tags at its N-terminus (n=28, 13, 17, 580 
14 and 11 cells). d, Efficiency of intracellular labelling with the cell permeable CLIP substrate 581 
SiR-BC in cells transfected with CD86 carrying two CLIP tags at its C-terminus (n=18, 26, 31, 27 582 
cells).  Labelling efficiencies in c and d were determined by fitting single-particle intensity data 583 
with a mixed Gaussian model4. The following concentrations were chosen for subsequent 584 
experiments: 4 μM S549-BG (labelling efficiency 91.1±2.9%) and 8 μM SiR-BC (labelling 585 
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efficiency 82.6±2.1%). e, Specificity of labelling. Shown are TIRF images of CHO cells 586 
transfected with different combinations of SNAP-α2A-AR and Gαi-CLIP, followed by labelling with 587 
S549-BG or SiR-BC (except for the positive control cotransfected with SNAP-α2A-AR and Gαi-588 
CLIP, which was labelled with both fluorescent substrates). Unspecific labelling in either mock or 589 
cross-transfected cells was responsible for 2-3 spots per cell on average against ~300-400 in 590 
the positive controls. This very low number of unspecific immobile localizations (<1%) does not 591 
significantly interfere with the analyses of this study. f, Representative potential energy (V) maps 592 
calculated in mock-transfected cells. Shown are results obtained after adding simulated 593 
trajectories with Brownian motion to reproduce a condition of diffusing particles over immobile 594 
unspecific localizations. The presence of immobile unspecific localizations was not sufficient to 595 
generate local low potential energy areas (see Extended Data Fig. 4b for comparison). Data 596 
are mean±s.e.m. Images (e, f) represent 3 independent experiments. 597 
 598 
Extended Data Figure 2 | MSD analysis of receptor and G protein trajectories. a, Scatter 599 
plot of diffusion coefficient (D) and anomalous diffusion exponent (α) values estimated for 600 
simulated trajectories with Brownian motion and characteristics similar to those of α2A-ARs. The 601 
results were used to set the cut-offs for classifying the trajectories into four groups according to 602 
their motion: immobile (D<0.01 μm2 s-1), sub-diffusion (α<0.75), normal diffusion (0.75≤α≤1.25) 603 
and super-diffusion (α>1.25).  b, Scatter plot as in a for α2A-AR trajectories. c, Representative 604 
α2A-AR and Gαi trajectories classified in the four groups. d, Relative frequency distributions of 605 
the trajectories in the four groups (left) and corresponding D values (right) for receptors and G 606 
proteins under basal and stimulated conditions. The control CD86 was expressed together with 607 
wild-type α2A-AR and stimulated with NE to verify if the effects observed upon agonist 608 
stimulation were specific for Gαi. Differences in d are statistically significant by two-way ANOVA. 609 
#, P<0.05, ##, P<0.01 and ####, P<0.0001 vs. the corresponding basal condition and **, 610 
P<0.01, ***, P<0.001, ****, P<0.0001, vs. α2A-AR basal (top) or β2-AR basal (bottom) by Tukey's 611 
multiple comparison test. Data are mean±s.e.m. n=30 (9,273), 17 (6,623), 37 (8,309), 30 612 
(4,699), 18 (2,182), 36 (5,240), 28 (11,267), 27 (12,697), 29 (10,760), 47 (16,461), 29 (41,079) 613 
and 47 (7,585) cells (trajectories) for α2A-AR basal, α2A-AR NE, α2A-AR UK-14,304, Gαi basal, 614 
Gαi NE, Gαi UK-14,304, CD86 basal, CD86 NE, β2-AR basal, β2-AR Iso, Gαs basal, Gαs Iso, 615 
respectively. Images (c) represent 5 independent experiments. 616 
 617 
21 
 
Extended Data Figure 3 | Complete results of the hidden Markov model (HMM) analysis. 618 
Differences are statistically significant by two-way ANOVA. #, P<0.05, ##, P<0.01, ###, P<0.001 619 
and ####, P<0.0001 vs. the corresponding basal condition, and *, P<0.05, **,P<0.01, ***, 620 
P<0.001 and ****: P<0.0001 vs. α2A-AR basal (for Gαi and CD86) or β2-AR basal (for Gαs) by 621 
Tukey's multiple comparison test. Data are mean±s.d. n=22 (85,475), 11 (44,797), 31 (153,072), 622 
13 (47,062), 9 (15,161), 30 (88,397), 28 (110,907), 30 (147,222), 27 (142,243), 44 (229,815), 28 623 
(84,668) and 44 (171,623) cells (trajectories) for α2A-AR basal, α2A-AR NE, α2A-AR UK-14,304, 624 
Gαi basal, Gαi NE, Gαi UK-14,304, CD86 basal, CD86 NE, β2-AR basal, β2-AR Iso, Gαs basal, 625 
Gαs Iso, respectively. N.D., not determinable. 626 
 627 
Extended Data Figure 4 | Complex diffusion dynamics of α2A-AR and Gαi. a, density maps 628 
of α2A-AR and Gαi localizations (selected trajectories overlaid in different colours; arrowheads, 629 
areas of high density). b, Potential energy (V) maps for α2A-AR and Gαi, calculated for the same 630 
membrane region. c, Merge of potential energy maps in b (top) and line-profile plot along the 631 
dashed line (bottom). Arrowheads, hot spots where V is low for both α2A-AR and Gαi. d, 632 
Additional examples of α2A-AR potential energy (V) maps over actin PALM images and 633 
corresponding zoom-in views. Images represent 3 (a-c) and 2 (d) independent experiments. 634 
 635 
Extended Data Figure 5 | Complex diffusion dynamics of β2-AR and Gαs. a, β2A-AR 636 
localizations over Gαs potential energy (V) map and vice versa (top) and quantifications of 637 
relative potential energy at the localizations (VL,rel; bottom). A negative value indicates relatively 638 
lower potential energy at the localizations. b, β2-AR:Gαs interactions over merged β2-AR and 639 
Gαs potential energy map (top) and corresponding quantifications (bottom). Arrowheads, 640 
localizations concentrated at hot spots. c-e, β2-AR trajectories over images of tubulin (c), actin 641 
(d) or CCPs (e) (top) and corresponding colocalization analyses (bottom). Negative 642 
colocalization index (I) values indicate preferential avoidance of the imaged structures by the 643 
receptors. f, Trajectory of β2-AR stopping at CCP (arrowhead; top) and corresponding 644 
quantitative analysis (bottom). The trajectory is colour-coded according to the HMM states. 645 
Results in a-e were compared to those obtained with random localizations. See Supplementary 646 
Methods for details. Data are mean±s.d. n, number of cells. #, P<0.05, ##, P<0.01, ###, 647 
P<0.001, ####, P<0.0001 vs. random localizations by two-sided paired t-test. *, P<0.05, **, 648 
P<0.01, ***, P<0.001, ****, P<0.0001 vs. β2-AR (basal) by two-sided unpaired t-test. 649 
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 650 
Extended Data Figure 6 | Complex diffusion dynamics of Gαi. a, Gαi trajectories over actin 651 
PALM image. Arrowheads, Gαi subunits crossing over actin fibres. b, Gαi trajectories over 652 
image of CCPs. c, Gαi potential energy (V) map over PALM image of actin fibres (left) and 653 
corresponding zoom-in view (right). Images represent 2 (a, c) and 3 (b) independent 654 
experiments. 655 
 656 
Extended Data Figure 7 | Validation of the analysis of receptor:G protein interactions 657 
using simulated data. a-d, Test of the Lucy-Richardson (LR) deconvolution algorithm on data 658 
obtained with numerical simulations. A numerical simulation of particles interacting and 659 
dissociating following an exponential law (n=20,000 particles; koff=0.7 s-1) was performed. In 660 
addition, we considered particles undergoing random colocalizations (also terminating following 661 
an exponential law; n=20,000 particles; k=1.75 s-1). a, Underlying distribution of the interaction 662 
times for the true interactions. b, Distribution of the colocalization times for the random 663 
colocalizations. c, Convolution of the distribution in a with that in b, corresponding to the 664 
observed colocalization times. d, Deconvolution of the distribution in c with that in b. Note that 665 
the algorithm was capable of correctly retrieving the distribution of the true interaction times. e, 666 
f, Simulated two-channel image sequences of particles undergoing transient interactions. A 667 
defined fraction of particles in the first channel was simulated to undergo interactions with 668 
particles in the second channel. The synthetic image sequences were then analysed using 669 
automated particle detection and tracking as for the experimental ones. e, Representative frame 670 
of a simulated two-colour image sequence. f, Trajectories obtained by automated single-particle 671 
detection and tracking. g, Relaxation curve obtained from simulations of non-interacting 672 
particles. h, Relaxation curve obtained from simulations of interacting and non-dissociating 673 
particles. i, Result of the LR deconvolution analysis of the data in h with those in g. Data were 674 
fitted with an exponential decay, used to estimate the rate of premature termination (see 675 
Supplementary Methods). j, Results of the LR deconvolution analysis on simulated image 676 
sequences comparing the input dissociation rate constants (koff) and the ones estimated by the 677 
analysis. The results were corrected for premature termination of the interactions as described 678 
in Supplementary Methods. All simulations were repeated 3 times with similar results. 679 
 680 
Extended Data Figure 8 | Simulations with deterministic model of GPCR signalling. a, 681 
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Schematic representation of the model. r, inactive receptor. R, active receptor. L, ligand 682 
(agonist). b, Model reactions and kinetics parameters used in the simulations. c, d, FRET 683 
measurements of the ensemble kinetics of α2A-AR activation/deactivation in response to 684 
transient agonist stimulation. A sensor consisting in the α2A-AR carrying a FlAsH tag in the third 685 
intracellular loop and CFP at the C-terminus was used. Shown are a representative FRET 686 
measurement (c) and the normalized average of the FRET data (d; n=4 cells). e, Fitting of 687 
model parameters using the measured FRET data for receptor activation/deactivation. f, 688 
Concentration-response relationships for ligand binding, receptor activation and G protein 689 
activation generated with the model. g, h, Simulations of GPCR signalling in response to 690 
transient agonist stimulation, applying the estimated kon and koff for receptor:G protein 691 
interactions to the model. Simulations were performed both considering low (g) and high (h) 692 
receptor/G protein expression levels. i, j, FRET measurements of the ensemble kinetics of α2A-693 
AR:Gαi association/dissociation in response to transient agonist stimulation. A sensor consisting 694 
in the α2A-AR carrying YFP at the C-terminus and the Gαi1 subunit carrying CFP in the αA-αB 695 
loop within the α-helical domain was used. Shown are a representative FRET measurement (i) 696 
and the normalized average (n=16 cells) of the FRET data (j). Association and dissociation time 697 
constants (mean, 95%CI) were 44.4 (38.3-52.9) ms and 1.22 (1.16-1.29) s. k, Comparison 698 
between the FRET data in j and the result of simulation with the mathematical model. Data are 699 
mean±s.e.m. 700 
 701 
Extended Data Figure 9 | Hot spots for receptor:G protein interaction in primary human 702 
endothelial cells. a, α2A-AR:Gαi interactions over merged α2A-AR and Gαi potential energy (V) 703 
map (left) and corresponding quantifications (right). Arrowheads, α2A-AR:Gαi interactions 704 
concentrated at hot spots. b, Same analysis as in a for β2-AR and Gαs. ####, P<0.0001 vs. 705 
random localizations by two-sided paired t-test. c, Distribution of diffusion states (based on 706 
HMM analysis) of receptor/G protein trajectories during apparent interactions. Differences are 707 
statistically significant by chi-square test (****, P<0.0001; n=2,488,438 and 1,382,193 data 708 
points for α2A-AR and Gαi with NE stimulation; n=1,992,190 and 874,317 data points for α2A-AR 709 
and Gαi with UK-14,304 stimulation; n=5,073,163 and 3,959,938 data points for β2-AR and Gαs 710 
with Iso stimulation, respectively). Data (a, b) are mean±s.d. n, number of cells (a, b). 711 
 712 
Extended Data Figure 10 | Schematic summary. a, The complex organization of the plasma 713 
24 
 
membrane, including barriers provided by actin fibres, microtubules and CCPs, generates hot 714 
spots for receptor:G protein interaction and signalling. b, Receptors and G proteins undergo 715 
random collisions (preferentially within these hot spots), which, via very short-lived encounter 716 
complexes, only seldom lead to the formation of productive receptor:G protein (R:G) complexes 717 
(low kon). Most of these complexes dissociate with a lifetime of ~1-2 s, while very few are long-718 
lived. Agonists mainly act by increasing the kon for receptor:G protein interactions in a ligand-719 
specific manner. These data suggest that most receptor:G protein complexes are transient and 720 
that receptor:G protein interactions are not diffusion limited but rather controlled by the large 721 
conformational rearrangements occurring during the formation of productive receptor:G protein 722 
complexes. See also Supplementary Discussion. 723 
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